Pharma Bulls Roll With ETF Trade
The Health Care SPDR Fund hit an all-time high yesterday, and traders are betting that its pharmaceutical names still have more to gain.
Options have been quiet recently in the exchange-traded fund, but some activity in the March 44 calls and the April 45 calls stood out yesterday on OptionMonster's real-time tracking systems. Traders 3,500 March 44 contracts for $0.53 and, at the same time, bought 4,500 April 45s for $0.26.
These calls lock in the purchase price for the fund no matter how high it might rise, so they can generate leverage and provide cheap exposure to a rally.
The March contracts expire at the end of next week, so the traders rolled that position forward in time. They received a credit of $65,500 for selling those calls and can keep making money if the fund keeps climbing.
The fund rose 0.2 percent to $44.49 yesterday, its highest closing price ever. The overall session was heavily weighted to the calls, which totaled 12,600 contracts against fewer than 4,300 puts.
—By CNBC Contributor Pete Najarian
Options Trading School:
Pete Najarian is a professional investor, CNBC contributor, regular co-host of CNBC's "Fast Money" and co-founder of OptionMonster.com. Najarian has no XLV positions.